Mehmet Salih Iyikesici

Specjalizacja: Onkohematolog
29 lat doświadczenia
Języki:
English, Turkish
Miejsce pracy: Turcja, Stambuł, Szpital Central Hospital
Medical oncologist specializing in MSCT; author of peer-reviewed work on MSCT in rectal cancer (2020) and on outcomes in NSCLC and breast cancer (2004).
Assoc. Prof. Dr. Mehmet Salih İyikesici is a medical oncologist. He provides personalized care for breast, lung, and gastrointestinal cancers. He combines metabolically supported therapies with chemotherapy. His interests include the ketogenic diet in cancer care, hyperthermia, and hyperbaric oxygen therapy.

He has conducted and contributed to national and international scientific studies. Selected national peer-reviewed publications include Metabolic Supported Chemotherapy in Rectal Cancer (2020), NSCLC Patient Outcomes – Marmara University (2004), and Early-Stage Breast Cancer Outcomes (2004).

Usługi lekarza

Jak Państwo oceniają naszą usługę?

1 z 3

Informacje o tym lekarzu są pełne i zrozumiałe

Nie zgadzam się

Zdecydowanie zgadzam się

Kwalifikacje

Assoc. Prof. Dr. Mehmet Salih İyikesici is a Medical Oncology specialist. He provides personalized treatment, particularly for breast, lung, and gastrointestinal cancers, using metabolically supported therapies, chemotherapy, and innovative approaches. He has conducted and contributed to national and international scientific studies

Areas of Interest • Medical Oncology • Metabolic Supported Chemotherapy (MSCT) • Ketogenic diet in cancer treatment • Hyperthermia therapy • Hyperbaric oxygen therapy • Breast cancer • Lung cancer • Colorectal cancer • Pancreatic cancer

Publications in National Peer-Reviewed Journals • Metabolic Supported Chemotherapy in Rectal Cancer (2020) • NSCLC Patient Outcomes – Marmara University (2004) • Early-Stage Breast Cancer Outcomes (2004)